Association between ankylosing spondylitis and hearing loss: A Mendelian randomization study.
- 1Department of Rheumatology and Immunology, Guangdong Provincial People's Hospital Ganzhou Hospital, Ganzhou Municipal Hospital, Ganzhou, Jiangxi, China.
Abstract
Observational studies have suggested a potential link between ankylosing spondylitis (AS) and hearing loss. However, this association remains controversial due to potential drug-induced ototoxicity from treatments. Therefore, we employed a Mendelian randomization (MR) approach to evaluate the association between AS and hearing loss from a genetic perspective. This MR study utilized summary data from genome-wide association studies on AS and hearing loss, including sensorineural hearing loss (SNHL) and conductive hearing loss (CHL). The primary analysis was conducted using the inverse-variance weighted method. The primary analysis showed a causal effect of AS on both SNHL (odds ratio [OR] = 1.121, 95% confidence interval [CI]: 1.042-1.206, P = .002) and CHL (OR = 1.387, 95% CI: 1.123-1.712, P = .002). After excluding chromosome 6 variants, the association with CHL persisted (OR = 1.675, 95% CI: 1.212-2.315, P = .002), while the effect on SNHL was no longer significant (OR = 1.054, 95% CI: 0.942-1.181, P = .357). The primary inverse-variance weighted analysis showed no causal effect of SNHL on AS (OR = 0.984, 95% CI: 0.892-1.086, P = .747). Sensitivity analyses found no evidence of horizontal pleiotropy. This MR study suggests that AS is causally associated with higher risks of CHL and SNHL. The association with CHL appears independent of the chromosome 6 human leukocyte antigen region, whereas the risk for SNHL is largely driven by this region. These findings suggest that targeted audiometric evaluations should be considered for symptomatic patients with AS. Further studies are required to explore the specific mechanisms linking AS to different types of hearing loss.
Related
- The causal association between Celiac disease and Ankylosing spondylitis: a two-sample Mendelian randomization analysis.
- Association of 14 matrix metalloproteinases and 4 tissue inhibitors of metalloproteinases on ankylosing spondylitis : A bidirectional Mendelian randomization study
- Association of the CALLY Index with Short-Term Treatment Response in Ankylosing Spondylitis
- Left Ventricular Myocardial Deformation Abnormalities in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis): Association With Disease Severity Assessed by Two-Dimensional Speckle-Tracking Echocardiography
- The association between inflammation and pubertal development : Insights from NHANES and Mendelian randomization analyses
BibTeX
@article{yang2026association,
title = {{Association between ankylosing spondylitis and hearing loss: A Mendelian randomization study.}},
author = {Qingyuan Yang and Junlai Xu},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051185},
url = {https://europepmc.org/article/MED/42888601},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Association between ankylosing spondylitis and hearing loss: A Mendelian randomization study.
AU - Qingyuan Yang
AU - Junlai Xu
PY - 2026
DA - 2026/10/01
JO - Medicine
DO - 10.1097/md.0000000000051185
UR - https://europepmc.org/article/MED/42888601
AB - Observational studies have suggested a potential link between ankylosing spondylitis (AS) and hearing loss. However, this association remains controversial due to potential drug-induced ototoxicity from treatments. Therefore, we employed a Mendelian randomization (MR) approach to evaluate the association between AS and hearing loss from a genetic perspective. This MR study utilized summary data from genome-wide association studies on AS and hearing loss, including sensorineural hearing loss (SNHL) and conductive hearing loss (CHL). The primary analysis was conducted using the inverse-variance weighted method. The primary analysis showed a causal effect of AS on both SNHL (odds ratio [OR] = 1.121, 95% confidence interval [CI]: 1.042-1.206, P = .002) and CHL (OR = 1.387, 95% CI: 1.123-1.712, P = .002). After excluding chromosome 6 variants, the association with CHL persisted (OR = 1.675, 95% CI: 1.212-2.315, P = .002), while the effect on SNHL was no longer significant (OR = 1.054, 95% CI: 0.942-1.181, P = .357). The primary inverse-variance weighted analysis showed no causal effect of SNHL on AS (OR = 0.984, 95% CI: 0.892-1.086, P = .747). Sensitivity analyses found no evidence of horizontal pleiotropy. This MR study suggests that AS is causally associated with higher risks of CHL and SNHL. The association with CHL appears independent of the chromosome 6 human leukocyte antigen region, whereas the risk for SNHL is largely driven by this region. These findings suggest that targeted audiometric evaluations should be considered for symptomatic patients with AS. Further studies are required to explore the specific mechanisms linking AS to different types of hearing loss.
SN - 0304-5412
SN - 1536-5964
ER -